NSE: TATVA | BSE: 543321

Expensive Rocket

Download real time

1079.40 34.60 (3.31%)

73.82% Gain from 52W Low

52,252 NSE+BSE Volume

NSE 18 Aug, 2025 3:31 PM (IST)

2,524.9

Market Cap

Below industry Median

0.6

Beta 1Year

Very Low volatility

Tatva Chintan Pharma Chem Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for TATVA, BSE:543321 Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1079.40

3.31%

TATVA CHINTAN PHARMA CHEM LTD.

IPO Note: Tatva Chintan Pharma Chem ...

Ventura

IPO NOTE

Tatva Chintan Pharma Chem Ltd. has gained 55.69% in the last 6 Months

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1079.40

3.31%

Tatva Chintan Pharma Chem Ltd. IPO Note

IPO Note: Tatva Chintan Pharma Chem ...

Ashika Research

Public issue of 4,616,805 Equity shares of Face value Rs. Total Public 10 each, (Comprising of fresh issue of 2,077,562 Equity Shares* (Rs. 225 cr.) and Offer for Sale of 2,539,243 Equity Share Pre Issue (Nos. Cr.)...

Tatva Chintan Pharma Chem Ltd. has gained 40.36% in the last 3 Months

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1079.40

3.31%

Tatva Chintan Pharma Chem : IPO

IPO Note: Tatva Chintan Pharma Chem ...

ICICI Securities Limited

Incorporated in 1996, Tatva Chintan is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). Apart from customers in India, the company also exports products to over 25 countries, including the US, China, Germany, Japan, South Africa, and the UK. As on March 31,...

Tatva Chintan Pharma Chem Ltd. is trading above all available SMAs

VOTE: Is Tatva Chintan Pharma Chem Ltd. worth buying?

51 Votes:

Buy 56.86%

Sell 23.53%

Hold 19.61%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf